HER2 Support Group Forums - GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival In P

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival In P (https://her2support.org/vbulletin/showthread.php?t=42742)

News	12-12-2009 05:02 AM

GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival In P

In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab)...

More...

All times are GMT -7. The time now is 02:17 AM.